HomePCVX • NASDAQ
add
Vaxcyte Inc
Previous close
$30.90
Day range
$30.65 - $32.53
Year range
$27.66 - $121.06
Market cap
4.11B USD
Avg Volume
2.74M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 180.79M | 57.94% |
Net income | -140.72M | -48.09% |
Net profit margin | — | — |
Earnings per share | -1.04 | -22.22% |
EBITDA | -177.84M | -56.72% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.67B | 12.46% |
Total assets | 3.38B | 61.53% |
Total liabilities | 178.08M | 65.93% |
Total equity | 3.20B | — |
Shares outstanding | 129.00M | — |
Price to book | 1.24 | — |
Return on assets | -13.12% | — |
Return on capital | -13.56% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -140.72M | -48.09% |
Cash from operations | -166.27M | -4.49% |
Cash from investing | 123.32M | 127.34% |
Cash from financing | 759.00K | -99.91% |
Net change in cash | -41.03M | -119.17% |
Free cash flow | -151.73M | -11.53% |
About
Founded
2013
Headquarters
Website
Employees
414
